CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-11). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 290 · Search date 2026-07-11 · Methodology v0.6

Whole coffee fruit extract,
does it really help with Improvement in BDNF, focus, and memory?

30-Second Summary
C
Evidence Grade C · 45 · Safety acceptable
BDNF and some working-memory signals exist, but they are not independent evidence of clinical cognitive improvement
What the
research shows
Whole coffee fruit extract improved blood BDNF and some working-memory and response-inhibition measures in small trials. BDNF is a surrogate that cannot stand in for clinical cognitive improvement, however, and every identified single-ingredient trial was linked to the ingredient company through support or conflicts of interest, yielding C.
What the
ads claim
Claims of '143% higher BDNF' and 'better focus and memory' combine a single-dose blood biomarker with selected computerized tasks. Dementia prevention and everyday memory improvement were not directly tested.
*

Useful facts when choosing a product

  • Proprietary-ingredient studies generally used 100-200 mg/day.
  • Plasma or exosomal BDNF is not equivalent to clinical memory improvement.
  • Single-ingredient studies must be distinguished from phosphatidylserine combinations.
  • Key single-ingredient trials included manufacturer support or author conflicts.
Gap Measurement · Verdict 290 · C 45
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Reyes-Izquierdo 2013 trial reported increased plasma BDNF after a single 100 mg dose in 10 healthy participants. The Robinson 2021 crossover trial in eight older adults reported changes in BDNF, functional connectivity, and some reaction-time measures after 100 mg. The Robinson 2024 randomized trial reported improvements in selected working-memory and response-inhibition accuracy measures with 200 mg, but it was ingredient-company sponsored. A combined whole coffee cherry and phosphatidylserine trial cannot isolate this ingredient.

02

Why this is classified as C (45)

Human randomized trials and repeated signals rule out an unknown or D grade. Because all positive single-ingredient evidence is manufacturer-concentrated and centers on BDNF and brief tasks, the grade is capped at C; lack of independent replication yields 47 points.

Counterpoint. Repeated working-memory and response-inhibition signals remain. This verdict does not extend them to durable memory improvement or prevention of cognitive disease.

Rejudgment record. New verdict — Randomized-trial signals, but all positive single-ingredient evidence is manufacturer-linked and centered on BDNF surrogates and brief cognitive tasks

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Increase in blood BDNFCIt increased in small single-dose trials, but it is a surrogate and the evidence is manufacturer-concentrated.
Improvement in focus and memoryCSome working-memory and response-inhibition tasks were positive, but everyday memory and long-term outcomes remain untested.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Reyes-Izquierdo T et al. 2013Randomized single-dose controlled trial10Supported by FutureCeuticalsPlasma BDNFBDNF increased after one 100 mg dose; clinical cognition was not assessed.Supportive
Robinson JL et al. 2021Randomized double-blind placebo-controlled crossover trial8FutureCeuticals support and employee coauthorsBDNF, neuroimaging, and cognitive tasksSignals in BDNF and selected neurophysiological and reaction-time measures; extremely small sample.Key
Robinson JL et al. 2024Remote randomized double-blind placebo-controlled trial323FutureCeuticals sponsored with author conflictsWorking memory and response inhibitionSome acute and longitudinal accuracy measures improved with 200 mg; not clinical outcomes.Key
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-11).

Reyes-Izquierdo T, Nemzer B, Shu C, et al. Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects. Br J Nutr. 2013;110(3):420-425. PMID: 23312069. DOI: 10.1017/S0007114512005338.
checked
Robinson JL, Yanes JA, Reid MA, et al. Neurophysiological Effects of Whole Coffee Cherry Extract in Older Adults with Subjective Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study. Antioxidants (Basel). 2021;10(2):144. PMID: 33498314. DOI: 10.3390/antiox10020144.
checked
Robinson JL, Hunter JM, Kern M, et al. Whole Coffee Cherry Extract Improves Working Memory and Response Inhibition: Acute and Longitudinal Results from a Remote, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2024;16(14):2348. PMID: 39064791. DOI: 10.3390/nu16142348.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none

Cite this verdict

Whole coffee fruit extract (NeuroFactor/CognatiQ) x improvement in BDNF, focus, and memory Evidence Grade C card
[Chamgap] Whole coffee fruit extract (NeuroFactor/CognatiQ) x improvement in BDNF, focus, and memory — Evidence Grade C·45. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/cognition/whole-coffee-fruit-bdnf-cognition/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.